Molina Healthcare, Inc. MOH is like a sturdy ship sailing through choppy waters, showing promise with increasing memberships, expanding premiums, contract victories, and a boost in investment income. This Long Beach, CA-based company, valued at $23.6 billion, steers through the competitive seas of managed healthcare services under government-sponsored healthcare programs. Sitting steady as a Zacks Rank #3 (Hold), Molina Healthcare’s voyage seems worth continuing for now.
In this voyage of discovery, we’ll navigate through the factors steering the company’s growth and expectations, pointing out key indicators for investors to monitor.
Diving into the deep waters, the Zacks Consensus Estimate for MOH’s 2024 earnings stands at $23.62 per share, signaling a robust 13.1% year-over-year growth. With stability in the estimate over recent days, Molina Healthcare emerged victorious in beating earnings expectations over the past four quarters, showcasing an average 7.6% surprise. This impressive record is displayed below.
The Earnings Surprise
Upward Trajectory | Molina Healthcare, Inc Quote
The anticipated revenue for 2024 stands tall at $39.6 billion, forecasting a 16.1% rise from the previous year. Molina Healthcare seems set to capitalize on burgeoning premium revenues and a surge in investment income. Projections suggest a 16.5% boost in premium revenues and a remarkable 28.2% surge in investment income year-over-year.
In the turbulent waters of the market, Molina Healthcare’s shares have soared by 54.8% in the past year, overshadowing the sluggish 6% growth in the medical industry, the Medical sector’s marginal 8.3% uptick, and the S&P 500’s modest increase of 29.4%. This unparalleled performance indicates strength in operation, hinting at a sustained upward journey.
With increased premiums from Medicaid, Medicare, and Marketplace businesses, alongside a flourishing membership base, Molina Healthcare is set to chart a course towards revenue growth. Total memberships are projected to surge by approximately 14% in 2024, driven by an estimated 12% rise in Medicaid memberships and nearly 30% boost in Marketplace enrollments. The expansion of Medicare memberships acts as a significant tailwind in this positive story.
Forecasting a rise in adjusted net income to $1.4 billion by 2024, marking a solid 12.6% uptick from the previous year, Molina Healthcare’s strategic acquisitions like My Choice Wisconsin, Brand New Day, and Central Health Plan of California demonstrate its commitment to diversity and geographical expansion, bolstering its growth strategy.
By hoisting its sails with $4.8 billion in cash and equivalents at the end of the fourth quarter, a hefty sum towering over its long-term debt of $2.2 billion, Molina Healthcare stands with a resilient balance sheet, showcasing its financial prowess. Noteworthy is the 115% surge in net cash from operating activities to $1.7 billion in 2023, a testament to its expanding horizons.
Navigational Challenges
Yet, as we scan the horizon, investors must keep a weather eye on a few areas. The mounting total operating expenses, escalating by 45.8% in 2021, 15.1% in 2022, and 5.5% in 2023, with a projected leap of nearly 16% this year, could cast a shadow on Molina Healthcare’s margins. Moreover, the current rich valuation, with a forward 12-month price-to-earnings ratio of 16.83X, over the industry’s average of 15.66X, poses a challenge. Nonetheless, a well-charted and strategic course of action is believed to steer Molina Healthcare towards long-term growth.
Top Healthcare Picks
Expanding the breadth of healthcare options, there are several promising stocks in the Medical sector worth looking at. These include Universal Health Services, Inc. UHS, The Cigna Group CI, and Health Catalyst, Inc. HCAT, each holding a Zacks Rank #2 (Buy) currently. Explore more with today’s Zacks #1 Rank (Strong Buy) stocks here.
With Universal Health Services, Inc., the 2024 bottom line is forecasted to witness a robust 22.4% year-over-year growth, reflecting optimism with consistent upward estimate revisions and formidable past performance.
Cigna Group’s 2024 outlook shines with a projected 13% year-over-year increase in earnings and a 20.4% revenue surge from the year before, bolstered by its continued earnings beat streak.
Health Catalyst, Inc. displays an impressive trajectory, with a staggering 113.3% year-over-year surge in 2024 earnings forecast and a remarkable track record of exceeding earnings estimates, signaling a strong growth potential.
Dive into the Future of Oil Stocks
Global oil demand is soaring, and oil companies are struggling to keep pace. Though oil prices have dipped, opportunities for significant profits remain on the horizon.
Zacks Investment Research has released a special report, Oil Market on Fire, uncovering four unexpected oil and gas stocks poised for substantial gains in the coming months. These recommendations are not to be missed. Download the report now.
Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
Molina Healthcare, Inc (MOH) : Free Stock Analysis Report
Cigna Group (CI) : Free Stock Analysis Report
Health Catalyst, Inc. (HCAT) : Free Stock Analysis Report
Read more on this topic at Zacks.com
As the sails of opinions unfurl, the perspective shared here belongs to the author and does not necessarily align with those of Nasdaq, Inc.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
